IntroductionThe gut microbiota (GM) play a significant role in the infectivity and severity of COVID-19 infection. However, the available literature primarily focuses on adult patients and it is known that the microbiota undergoes changes throughout the lifespan, with significant alterations occurring during infancy and subsequently stabilizing during adulthood. Moreover, children have exhibited milder symptoms of COVID-19 disease, which has been associated with the abundance of certain protective bacteria. Here, we examine the metaproteome of pediatric patients to uncover the biological mechanisms that underlie this protective effect of the GM.MethodsWe performed nanoliquid chromatography coupled with tandem mass spectrometry on a high resolution analytical platform, resulting in label free quantification of bacterial protein groups (PGs), along with functional annotations via COG and KEGG databases by MetaLab-MAG. Additionally, taxonomic assignment was possible through the use of the lowest common ancestor algorithm provided by Unipept software.ResultsA COVID-19 GM functional dissimilarity respect to healthy subjects was identified by univariate analysis. The alteration in COVID-19 GM function is primarily based on bacterial pathways that predominantly involve metabolic processes, such as those related to tryptophan, butanoate, fatty acid, and bile acid biosynthesis, as well as antibiotic resistance and virulence.DiscussionThese findings highlight the mechanisms by which the pediatric GM could contribute to protection against the more severe manifestations of the disease in children. Uncovering these mechanisms can, therefore, have important implications in the discovery of novel adjuvant therapies for severe COVID-19.

Marzano, V., Mortera, S.l., Marangelo, C., Piazzesi, A., Rapisarda, F., Pane, S., et al. (2023). The metaproteome of the gut microbiota in pediatric patients affected by COVID-19. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 13, 1-19 [10.3389/fcimb.2023.1327889].

The metaproteome of the gut microbiota in pediatric patients affected by COVID-19

Marzano V.;Pane S.;Romani L.;Palma P.;
2023-12-22

Abstract

IntroductionThe gut microbiota (GM) play a significant role in the infectivity and severity of COVID-19 infection. However, the available literature primarily focuses on adult patients and it is known that the microbiota undergoes changes throughout the lifespan, with significant alterations occurring during infancy and subsequently stabilizing during adulthood. Moreover, children have exhibited milder symptoms of COVID-19 disease, which has been associated with the abundance of certain protective bacteria. Here, we examine the metaproteome of pediatric patients to uncover the biological mechanisms that underlie this protective effect of the GM.MethodsWe performed nanoliquid chromatography coupled with tandem mass spectrometry on a high resolution analytical platform, resulting in label free quantification of bacterial protein groups (PGs), along with functional annotations via COG and KEGG databases by MetaLab-MAG. Additionally, taxonomic assignment was possible through the use of the lowest common ancestor algorithm provided by Unipept software.ResultsA COVID-19 GM functional dissimilarity respect to healthy subjects was identified by univariate analysis. The alteration in COVID-19 GM function is primarily based on bacterial pathways that predominantly involve metabolic processes, such as those related to tryptophan, butanoate, fatty acid, and bile acid biosynthesis, as well as antibiotic resistance and virulence.DiscussionThese findings highlight the mechanisms by which the pediatric GM could contribute to protection against the more severe manifestations of the disease in children. Uncovering these mechanisms can, therefore, have important implications in the discovery of novel adjuvant therapies for severe COVID-19.
22-dic-2023
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/38
English
COVID-19
SARS-CoV-2
functional patterns
gut microbiota
mass spectrometry
metaproteomics
pediatrics
Marzano, V., Mortera, S.l., Marangelo, C., Piazzesi, A., Rapisarda, F., Pane, S., et al. (2023). The metaproteome of the gut microbiota in pediatric patients affected by COVID-19. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 13, 1-19 [10.3389/fcimb.2023.1327889].
Marzano, V; Mortera, Sl; Marangelo, C; Piazzesi, A; Rapisarda, F; Pane, S; Del Chierico, F; Vernocchi, P; Romani, L; Campana, A; Palma, P; Putignani, L
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
fcimb-13-1327889.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 4.57 MB
Formato Adobe PDF
4.57 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/363183
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact